Acer Therapeutics Inc (NASDAQ:ACER)

5.11
Delayed Data
As of Aug 10
 -0.30 / -5.55%
Today’s Change
1.08
Today|||52-Week Range
7.25
+27.43%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 3.52. The median estimate represents a +95.69% increase from the last price of 5.11.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Acer Therapeutics Inc. This rating has held steady since February, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.38
Sales
$0.00
Reporting Date
Aug 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.27%
 
 
 
 
 
 
Growthannually 53.06%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.